000 01319 a2200385 4500
005 20250511181338.0
264 0 _c19921103
008 199211s 0 0 eng d
022 _a0392-856X
040 _aNLM
_beng
_cNLM
100 1 _aRacadot, E
245 0 0 _aImmunological follow-up of 17 patients with rheumatoid arthritis treated in vivo with an anti-T CD4+ monoclonal antibody (B-F5)
_h[electronic resource]
260 _bClinical and experimental rheumatology
_c
300 _a365-74 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aArthritis, Rheumatoid
_xblood
650 0 4 _aC-Reactive Protein
_xanalysis
650 0 4 _aCD4 Antigens
_xblood
650 0 4 _aCD4-Positive T-Lymphocytes
_ximmunology
650 0 4 _aCD8 Antigens
_xblood
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aInterleukin-6
_xblood
650 0 4 _aMiddle Aged
650 0 4 _aPilot Projects
650 0 4 _aReceptors, Interleukin-2
_xanalysis
650 0 4 _aT-Lymphocyte Subsets
_ximmunology
650 0 4 _aTumor Necrosis Factor-alpha
_xanalysis
700 1 _aWijdenes, J
700 1 _aWendling, D
773 0 _tClinical and experimental rheumatology
_gvol. 10
_gno. 4
_gp. 365-74
999 _c1363180
_d1363180